AzTrials
AzTrials

CravingNCT07157124

Examining the Effectiveness of Dynamic Visual Noise (DVN) for Reducing Alcohol Cravings and Consumption in College Students

A study testing Dynamic Visual Noise (DVN) and Static Visual Noise (SVN) in people with Craving and Alcohol Drinking, run by University of Wyoming at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to examine whether dynamic visual noise (DVN), a short video array of rapidly moving black and white squares, reduces cravings for and consumption of alcohol in college students who drink alcohol and experience cravings for alcohol at least once a week on average. Read more about this study

Who is it for?
Ages 18 to 29 years
Conditions the study is for
Craving, Alcohol Drinking
What is being tested?
Dynamic Visual Noise (DVN) and Static Visual Noise (SVN)
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
62 participants
Where
1 siteUnited States
Study dates
22 Sep 2025to Sep 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 29 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Must report being between the age of 18 and 29
  • Must report drinking alcohol at least once per week on average over the past month
  • Must report having drank beer or alcoholic seltzers in the past month
  • Must endorse experiencing craving at least once per week over the past month, on average
  • Must report not currently receiving nor planning to seek any other treatment for their alcohol use within the next 30 days
  • Must report owning a personal electronic device with access to the Internet
  • Must report owning or having access to a computer with access to the Internet

Who cannot join

  • Major visual impairment (i.e., legal blindness or color blindness)
  • History of seizures and/or diagnosed seizure disorder
  • Current medical diagnosis provided by a qualified professional (i.e., psychologist, psychiatrist, neurologist) that is characterized by cognitive impairment (i.e., neurocognitive disorder due to traumatic brain injury, traumatic brain injury, HIV infection, post-concussive syndrome, and intellectual disability)
  • Concussion in the past month
  • A current diagnosis of any substance use disorder besides alcohol use disorder, as determined by a qualified professional (i.e., psychologist, psychiatrist)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Emma Winterlind, MPS contact

307-314-2177

ewinterl@uwyo.edu

Alison Looby, PhD contact

alooby@uwyo.edu

United States1 site, 1 recruiting
  • University of Wyoming

    Laramie, Wyoming, 82072

    Emma L Winterlind, MPS, 307-314-2177, ewinterl@uwyo.edu

    Alison Looby, PhD, alooby@uwyo.edu

    Recruiting

Other trials in United States

About this study

Official title: A Theory-Informed Examination of a Brief Visuospatial Intervention and Its Mechanisms for Reducing Alcohol Cravings and Consumption

The goal of this clinical trial is to examine whether dynamic visual noise (DVN), a short video array of rapidly moving black and white squares, reduces cravings for and consumption of alcohol in college students who drink alcohol and experience cravings for alcohol at least once a week on average. A second goal of this clinical trial is to examine whether changes in attentional bias towards alcohol (that is, the tendency to pay greater mental and visual attention towards alcohol over other things in one's environment) is a mechanism by which DVN reduces alcohol cravings and consumption.

Researchers will compare DVN to static visual noise (SVN), which is a still image of black and white squares that has been used as a control condition for DVN in prior literature.

Read more

Participants will:

  1. Visit the laboratory once to complete the baseline data collection
  2. Watch the DVN or SVN every day for seven days (including the day of the laboratory visit)
  3. Complete daily follow-ups for six days following the day of the laboratory visit
  4. Complete a final follow-up on the seventh day following the laboratory visit
Being tested
Dynamic Visual Noise (DVN), Static Visual Noise (SVN)
Keywords
alcohol craving, dynamic visual noise, alcohol consumption, attentional bias, craving, alcohol, DVN, static visual noise, SVN
Medical subject headings
Alcohol Drinking

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Dynamic Visual Noise (DVN)Other

    DVN is a brief visual array of patterns of flickering black and white dots. In alignment with prior literature, the DVN array will consist of an 80 x 80 grid of 4 x 4 black and white pixel squares that will change at a rate of 640 frames per second. The DVN will be 30 seconds in duration, though participants will be able to keep watching for as long as desired by restarting the video of the array.

  • Static Visual Noise (SVN)Other

    SVN is similar to DVN, but refers to a static (or still) image of an array of black and white squares. The SVN will consist of an 80 x 80 grid of 4 x 4 black and white pixel squares. SVN has been used in previous working memory-loading studies as a control for DVN. Similar to the DVN, participants in the control group will view the SVN for at least 30 seconds (but they will be able to keep viewing it for as long as desired).

Study groups in NCT07157124
Study groupRoleWhat they receive
Dynamic Visual Noise (DVN)ExperimentalNot described
Receives: Other: Dynamic Visual Noise (DVN)
Static Visual Noise (SVN)Sham comparatorNot described
Receives: Other: Static Visual Noise (SVN)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Strength of Alcohol Craving

    Strength of alcohol craving will be measured using the Craving Experiences Questionnaire - Strength (CEQ-S). The measure inquires about the individual's past-week craving experiences. Higher average scores indicate stronger past-week cravings. Changes in mean craving will be calculated as changes in mean strength of past-week alcohol craving at follow-up relative to baseline for each condition.

    Measured: Baseline and 1-week follow-up

  2. Frequency of Craving

    Frequency of alcohol craving will be measured using the Craving Experiences Questionnaire - Frequency (CEQ-F). The measure inquires about the individual's past-week craving experiences. Higher average scores indicate more frequent past-week craving. Changes will be calculated as changes in mean frequency of past-week alcohol craving at follow-up relative to baseline for each condition.

    Measured: Baseline and 1-week follow-up

  3. Alcohol Consumption

    At baseline and follow-up, participants will complete the Daily Drinking Questionnaire (DDQ) to indicate the extent of their past-week alcohol consumption. Higher total scores indicate more past-week alcohol consumption. Changes will be calculated as changes in mean past-week alcohol use at follow-up relative to baseline for each condition.

    Measured: Baseline and 1-week follow-up

  4. Attentional Bias towards Alcohol

    Attentional bias will be measured at the initial laboratory session and at the 1-week final follow-up via the Alcohol Visual Probe task. Changes will be examined as mean changes in reaction time at follow-up minus reaction time at baseline for each condition.

    Measured: Baseline and 1-week follow-up

Secondary outcomes (2)
  1. Immediate Changes in Strength of Alcohol Craving Before and After DVN/SVN Task

    Participants will view their assigned intervention (i.e., DVN or SVN) as part of the initial baseline visit. Participants will first undergo a craving induction paradigm. Participants will then complete the CEQ-Strength-Now (CEQ-S-N) to indicate the strength of their current craving. Then, participants will view the DVN or SVN (depending on their assigned condition). After viewing the task, participants will complete the CEQ-S-N again. Higher average scores on the CEQ-S-N indicate stronger current moment cravings. Immediate changes in craving will be calculated as the average CEQ-S-N score before viewing the task minus average CEQ-S-N score after viewing the task. A mean change score will be calculated for each condition.

    Measured: Baseline

  2. Immediate Changes in Strength of Craving Before and After DVN/SVN

    During the intervention phase, participants will be able to freely access their assigned intervention whenever they experience a craving. When they access the intervention, participants will first be asked to indicate, using a 0-100 Visual Analogue Scale (VAS), the strength of their current cravings for alcohol (i.e., "How strong is your craving for alcohol RIGHT NOW?"). They will then view their assigned intervention for at least 30 seconds. Immediately after viewing their intervention, they will complete the same VAS item. The change score will be calculated as the craving score before viewing minus the craving score after each viewing. A mean change score will be calculated for each condition.

    Measured: 1-Week Intervention Period, Between Baseline Visit and 1-week Follow-Up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Sep 2025
  2. Study start22 Sep 2025
  3. Primary completionSep 2026 (estimated)
  4. Study completionSep 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be block randomized by sex into one of the two arms.
Masking
None (open label)
Enrolment
62 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07157124
Sponsor's protocol ID
IRB-2025-162
Status last verified
Dec 2025
First submitted
21 Aug 2025
Last updated
29 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Dynamic Visual Noise (DVN) and Static Visual Noise (SVN) in people with Craving and Alcohol Drinking, run by University of Wyoming at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 29 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Emma Winterlind, MPS (307-314-2177, ewinterl@uwyo.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Strength of Alcohol Craving (time frame: Baseline and 1-week follow-up). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in